Lipid-lowering effect of the new drugs eniclobrate and beclobrate in patients with hyperlipidemia type II a and type II b.
Najemnik C, Lageder H, Regal H, Irsigler K.
Arzneimittelforschung. 1981;31(12):2168-9.
Saturated fat from dairy sources and cardio-metabolic health: insights from the STANISLAS cohort.
Wagner S, Girerd N, Lemonnier C, Yena K, Lamiral Z, Duarte K, Merkling T, Merckle L, Bozec E, Dougkas A, Hoge A, Guillaume M, Rossignol P, Nazare JA, Vors C, Boivin JM, Michalski MC.
Eur J Nutr. 2025 Aug 30;64(6):267. doi: 10.1007/s00394-025-03763-1.
[Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine].
Noseda G, Suvà F, Fragiacomo C.
Schweiz Med Wochenschr. 1985 Jul 27;115(30):1064-70.
N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.
Connor WE, DeFrancesco CA, Connor SL.
Ann N Y Acad Sci. 1993 Jun 14;683:16-34. doi: 10.1111/j.1749-6632.1993.tb35689.x.
Modulation of Hepatic Functions by Chicory (Cichorium intybus L.) Extract: Preclinical Study in Rats.
Krepkova LV, Babenko AN, Lemyaseva SV, Saybel OL, Sherwin CM, Enioutina EY.
Pharmaceuticals (Basel). 2023 Oct 16;16(10):1471. doi: 10.3390/ph16101471.
Effects of cardiovascular risk factors and pre-existing diseases on the short-term outcome of Takotsubo syndrome.
Mousavi RA, Schober A, Kronberger C, Han E, Litschauer B, Pichler G, Badr Eslam R.
Wien Klin Wochenschr. 2024 Dec;136(23-24):691-699. doi: 10.1007/s00508-024-02326-4. Epub 2024 Feb 6.
Effects of omega-3 fatty acids in hypertriglyceridemic states.
Connor WE.
Semin Thromb Hemost. 1988 Jul;14(3):271-84. doi: 10.1055/s-2007-1002789.
Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.
Winkler K, Schäfer JR, Klima B, Nuber C, Sattler A, Friedrich I, Köster W, Steinmetz A, Wieland H, März W.
Atherosclerosis. 1999 May;144(1):167-75. doi: 10.1016/s0021-9150(99)00051-9.
Tumor necrosis factor‑α and interleukin‑6 suppress microRNA‑1275 transcription in human adipocytes through nuclear factor‑κB.
Zhou YF, Fu ZY, Chen XH, Cui Y, Ji CB, Guo XR.
Mol Med Rep. 2017 Nov;16(5):5965-5971. doi: 10.3892/mmr.2017.7392. Epub 2017 Aug 29.
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Cariolou M, Ganotakis ES, Mikhailidis DP, Elisaf MS.
J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):211-21. doi: 10.1177/1074248406293732.
